NCT07490626 2026-03-27
Paracentesis
University of Utah
Phase NA Not yet recruiting
Clinical Trials
5 trialsNCT07397819 2026-02-09
Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy
Sun Yat-sen University
Phase 1/2 Recruiting
NCT06266091 2025-07-20
Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody
Wuhan YZY Biopharma Co., Ltd.
Phase 2 Completed
NCT06432296 2025-07-20
Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody
Wuhan YZY Biopharma Co., Ltd.
Phase 3 Active not recruiting
NCT07007988 2025-06-06
SIM0388-101
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Recruiting